DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $304,511,986 | +5.2% | 1,227,376 | +1.7% | 1.97% | +7.5% |
Q2 2023 | $289,517,040 | +4.0% | 1,206,321 | +9.2% | 1.84% | +8.3% |
Q1 2023 | $278,501,428 | +109.3% | 1,104,989 | +117.8% | 1.70% | +91.6% |
Q4 2022 | $133,059,800 | -46.8% | 507,339 | -47.6% | 0.88% | -50.3% |
Q3 2022 | $250,310,000 | -8.4% | 969,105 | -10.1% | 1.78% | +5.7% |
Q2 2022 | $273,235,000 | -20.3% | 1,077,764 | -7.8% | 1.68% | -9.5% |
Q1 2022 | $342,736,000 | +870.6% | 1,168,431 | +916.7% | 1.86% | +917.5% |
Q4 2021 | $35,313,000 | -4.4% | 114,929 | -5.3% | 0.18% | -22.8% |
Q3 2021 | $36,947,000 | +75.2% | 121,359 | +54.4% | 0.24% | +61.2% |
Q2 2021 | $21,094,000 | +24.0% | 78,603 | +4.0% | 0.15% | +10.5% |
Q1 2021 | $17,006,000 | -71.5% | 75,554 | -71.8% | 0.13% | -70.2% |
Q4 2020 | $59,568,000 | -29.6% | 268,156 | -31.8% | 0.45% | -38.1% |
Q3 2020 | $84,617,000 | +68.1% | 392,962 | +38.0% | 0.72% | +48.0% |
Q2 2020 | $50,340,000 | – | 284,679 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |